首頁 > 市場調查報告書 > 醫療設備

心血管設備循環系統

市場調查報告書

商品編碼

1623503

全球心房顫動手術市場規模：地區、範圍和預測

Global Atrial Fibrillation Surgery Market Size By Procedure (Catheter Ablation Procedures, Surgical Ablation/Maze Procedures), By Product (Catheter Ablation Product Market, Surgical Ablation Market), By Geographic Scope And Forecast

出版日期: 2024年08月26日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

心房顫動手術市場規模及預測

2023年心房顫動手術市場規模為25.106億美元，在2024-2031年預測期間複合年增長率為14.10%，到2031年將達到72.1212億美元。

心房顫動手術的全球市場推動因素

心房顫動手術市場的市場推動因素可能受到多種因素的影響。

心房顫動 (AF) 的盛行率：

在世界各地，由於人口老化以及肥胖、糖尿病和高血壓等危險因子的增加，心房顫動變得越來越常見。因此，對包括手術在內的醫療照護的需求正在增加。

技術進步：

手術方法、設備和影像技術的進步使得更安全、更有效率的心房顫動手術成為可能。侵入性較小的手術和改進的消融技術吸引了患者和醫療保健專業人員的興趣，推動了市場擴張。

擴展知識和診斷：

患者和醫療保健專業人員越來越意識到與心房顫動 (AF) 相關的風險，從而能夠及早發現和治療。隨著越來越多的人被診斷出患有房顫，對心房顫動進行手術治療的需求也增加。

微創手術需求：

越來越多的患者尋求與開放性手術相比恢復更快、住院時間更短、併發症更少的微創治療。由於患者對微創手術的需求，心房顫動手術變得越來越普遍。

醫療保健支出增加：

由於全球醫療保健支出增加和基礎設施改善，更多的資源被投入心臟治療，特別是心房顫動 (AF) 的手術治療。這種類型的資本投資是市場擴張的驅動力。

支持手術的臨床證據：

隨著越來越多的臨床研究證明手術治療心房顫動的安全性和有效性，患者和醫療保健專業人員越來越有可能選擇手術治療，推動市場擴張。

政府計劃和付款規則：

政府計劃鼓勵心房顫動手術，以減輕心血管疾病的負擔並改善獲得醫療保健服務的機會。這些措施也得到有利的支付規則的支持。

新興國家：

在心房顫動盛行率上升的地區，由於新興國家經濟的快速成長、醫療基礎設施的進步以及醫療保健意識的提高，市場拓展前景廣闊。

限制全球心房顫動手術市場的因素

有幾個因素可能會成為心房顫動手術市場的市場限制和課題。

成本高：

心房顫動手術費用昂貴，這可能會限制無力承擔手術或保險不足的人的手術機會。

風險和併發症：

一般的手術，包括心房顫動手術，都有風險。出血、感染以及對周圍組織和器官的傷害等併發症可能會阻礙患者和醫生進行手術。

效果有限：

儘管手術是治療心房顫動的有效方法，但不一定能帶來長期解決方案。有些人手術後可能會再次出現心房顫動，這會讓患者不高興並需要進一步治療。

技術困難

需要改進手術方法和設備來改善手術結果並降低風險。然而，心房顫動治療的有效性可能會受到新技術開發和使用緩慢的限制。

替代療法

藥物和基於導管的手術（例如消融）通常可以有效控制心房顫動。如果患者選擇這些治療方法或醫生推薦這些治療方法，則可能會減少手術的需要。

監管障礙

新手術程序和設備的冗長而嚴格的審批程序可能會阻礙心房顫動手術領域的市場進入和創新。

缺乏知識：

許多心房顫動患者不知道可用的手術選擇或錯誤判斷他們的疾病有多嚴重，這可能導致他們推遲獲得所需的幫助。

培訓和技術：

房顫手術需要專門的訓練和技術。有些患者無法接受手術治療。這是因為該地區很少有資格進行手術治療的外科醫生。

Safer and more efficient atrial fibrillation procedures are now possible thanks to advancements in surgical methods, equipment, and imaging technology. Improvements include less intrusive techniques and enhanced ablation technology draw in patients and medical professionals, propelling the market's expansion.

Growing Knowledge and Diagnosis:

Patients and medical professionals are becoming more aware of the dangers connected to atrial fibrillation (AF), which is resulting in early detection and treatment. The need for surgical treatment options for atrial fibrillation (AF) is increasing as more people get the diagnosis.

Demand for Minimally Invasive Procedures:

In comparison to open operations, patients are increasingly looking for minimally invasive treatment options that offer quicker recovery times, shorter hospital stays, and less complications. Atrial fibrillation surgeries are becoming more common due to patient demand for less intrusive procedures.

Growing Healthcare Expenditure:

More funds are being devoted to cardiac care, particularly surgical treatments for atrial fibrillation (AF), as a result of global healthcare expenditure growth and infrastructural improvements. This monetary commitment drives market expansion.

Clinical Evidence in Support of Surgery:

As more clinical research shows the safety and effectiveness of surgical treatments for AF, patients and healthcare professionals are more likely to explore these choices, which propels market expansion.

Government programs and payment rules:

The use of atrial fibrillation surgeries is encouraged by government programs that lower the burden of cardiovascular diseases and increase access to healthcare services. These initiatives are also supported by advantageous payment rules.

Emerging countries:

In areas where the prevalence of AF is rising, there are substantial prospects for market expansion due to the rapid economic growth in emerging countries, as well as the advancement of healthcare infrastructure and raised healthcare awareness.

Global Atrial Fibrillation Surgery Market Restraints

Several factors can act as restraints or challenges for the Atrial Fibrillation Surgery Market. These may include:

High Cost:

Because atrial fibrillation procedures can be costly, access for people who cannot afford them or whose insurance does not cover them adequately may be restricted.

Risk and Complications:

Surgery in general, including atrial fibrillation surgery, carries certain inherent hazards. Surgery might be discouraged by complications such as bleeding, infection, or harm to surrounding tissues or organs for both patients and doctors.

Limited Efficacy:

Although surgery is a viable treatment option for atrial fibrillation, it may not always result in a long-term resolution. After surgery, some individuals may develop atrial fibrillation again, which could leave them unhappy and necessitate additional treatments.

Technological Difficulties:

Improving results and lowering dangers requires advances in surgical methods and equipment. Nevertheless, the effectiveness of atrial fibrillation procedures may be limited by the sluggish development and use of new technologies.

Alternative Therapies:

Medication and catheter-based techniques like ablation are frequently effective in managing atrial fibrillation. There may be less need for surgical procedures if patients choose these options or if doctors advocate them.

Regulatory Obstacles:

Long and rigorous regulatory approval procedures for novel surgical methods or equipment can impede market entry and innovation in the atrial fibrillation surgery space.

Lack of Knowledge:

Many people with atrial fibrillation may not be aware of the surgical alternatives available to them or may misjudge how serious their disease is, which can cause them to put off getting the help they need.

Training and Skill:

Specialized training and skills are needed for atrial fibrillation procedures. Some patients may not be able to receive surgical therapy because there may not be as many qualified surgeons doing these procedures in a given area.

Global Atrial Fibrillation Surgery Market Segmentation Analysis

The Global Atrial Fibrillation Surgery Market is Segmented on the basis of Type of Surgery, Surgical Approach, End-User, and Geography.

Atrial Fibrillation Surgery Market, By Type of Surgery

Catheter Ablation:
A minimally invasive procedure where a catheter is inserted through blood vessels to the heart, delivering energy (such as radiofrequency or cryotherapy) to destroy or isolate abnormal electrical pathways causing atrial fibrillation.
Surgical Ablation:
Invasive surgical procedures performed in an operating room, involving the creation of scar tissue on the heart's surface (either through open-heart surgery or minimally invasive techniques) to disrupt abnormal electrical signals and restore normal heart rhythm.
Maze Procedure:
A type of surgical ablation that creates a series of scar lines on the atria to block abnormal electrical impulses, typically performed during open-heart surgery but may also be done minimally invasively.

Atrial Fibrillation Surgery Market, By Surgical Approach

Minimally Invasive Surgery:
Surgical procedures performed through small incisions using specialized instruments and cameras, offering advantages such as reduced postoperative pain, shorter recovery times, and lower risk of complications compared to traditional open-heart surgery.
Open-Heart Surgery:
Traditional surgical procedures performed through a sternotomy (opening the chest cavity) to access the heart, allowing for direct visualization and manipulation of cardiac structures, often necessary for complex cases or combined procedures.

Atrial Fibrillation Surgery Market, By End-User

Hospitals and Clinics:
Medical facilities equipped with surgical suites and specialized cardiac care units, where atrial fibrillation surgeries are performed by cardiothoracic surgeons and electrophysiologists.
Ambulatory Surgical Centers (ASCs):
Outpatient facilities that provide surgical services for atrial fibrillation and other cardiac conditions in a more convenient and cost-effective setting than hospitals, often preferred for minimally invasive procedures.
Specialty Cardiac Centers:
Centers of excellence or specialized clinics dedicated to cardiac care, offering comprehensive evaluation, treatment, and follow-up care for patients with atrial fibrillation and other arrhythmias.

Atrial Fibrillation Surgery Market, By Geography

North America:
Market dynamics and trends specific to the atrial fibrillation surgery industry in North American regions, including the United States, Canada, and Mexico.
Europe:
Market factors and regulatory influences shaping the atrial fibrillation surgery market across European countries such as the UK, Germany, France, and Italy.
Asia Pacific:
Growth opportunities and market expansion strategies relevant to atrial fibrillation surgery in countries like China, India, Japan, and South Korea.
Latin America:
Market trends and consumer preferences impacting the atrial fibrillation surgery market in Latin American regions like Brazil, Argentina, and Chile.
Middle East and Africa:
Factors driving demand for atrial fibrillation surgery in regions like the Middle East and Africa, including increasing prevalence of cardiovascular diseases, improving healthcare infrastructure, and rising adoption of advanced surgical techniques.

Key Players

The "Global Atrial Fibrillation Surgery Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
Biosense Webster, Inc., Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Atricure, Inc., Cardiofocus, Inc., Ncontact, Inc., Carima, Inc., Abbott Laboratories, Johnson & Johnson, CryoLife, Inc., Osypka AG, BIOTRONIK SE & Co. KG and Biotroik Se & Co.Kg.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.